Cargando…
Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis
BACKGROUND: The identification of novel targets for recovering sorafenib resistance is pivotal for Hepatocellular carcinoma (HCC) patients. Mitophagy is the programmed degradation of mitochondria, and is likely involved in drug resistance of cancer cells. Here, we identified hyperactivated mitophagy...
Autores principales: | Wu, Hong, Wang, Tao, Liu, Yiqiang, Li, Xin, Xu, Senlin, Wu, Changtao, Zou, Hongbo, Cao, Mianfu, Jin, Guoxiang, Lang, Jinyi, Wang, Bin, Liu, Baohua, Luo, Xiaolin, Xu, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720487/ https://www.ncbi.nlm.nih.gov/pubmed/33280610 http://dx.doi.org/10.1186/s13046-020-01768-8 |
Ejemplares similares
-
Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
por: Xie, Xiao-Qing, et al.
Publicado: (2023) -
AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability
por: Di Rienzo, Martina, et al.
Publicado: (2021) -
The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization
por: Li, Quanfu, et al.
Publicado: (2022) -
Blame ATAD5 for factory closures
por: Leslie, Mitch
Publicado: (2013) -
Tumor-Promoting ATAD2 and Its Preclinical Challenges
por: Liu, Haicheng, et al.
Publicado: (2022)